GALANTAMINE SR CH galantamine (as hydrobromide) 16mg modified release capsules blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

galantamine hydrobromide, Quantity: 20.504 mg (Equivalent: galantamine, Qty 16 mg)

Available from:

Southern Cross Pharma Pty Ltd

INN (International Name):

Galantamine hydrobromide

Pharmaceutical form:

Capsule, modified release

Composition:

Excipient Ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; Gelatin; magnesium stearate; microcrystalline cellulose

Administration route:

Oral

Units in package:

28

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Product summary:

Visual Identification: opaque flesh-flesh size 2 hard gelatin capsule containing two round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2015-07-03